Skip to main content
. Author manuscript; available in PMC: 2014 Jul 8.
Published in final edited form as: Crit Rev Biochem Mol Biol. 2013 Sep 25;48(6):522–543. doi: 10.3109/10409238.2013.838202

Table 3.

Post translational modification on ETS transcription factors and functional effects related to oncogenesis

ETS protein Modifying
agents/Signaling
events
Type of post
translational
modification
Effects Pathology involving
changes in post
translational
modification
Reference
TEL MAPK Phosphorylation Loss of repression and export to nucleus Leukemia (Wood et al., 2003)
SUMO
conjugating
enzyme UBC9
Sumoylation
Ets-1 CAMKII Phopshorylation Inhibits DNA binding and transcriptional
activation
(Nelson et al., 2010,
Foulds et al., 2004)
MAPK Phosphorylation Allows for cooperative transcriptional
activation of Ets-1 and AP1, recruitment of
p300/CBP to Ets-1, and transcriptional
activation of MMP and uPA genes
TGFβ Acetylation Dissociation of p300/CBP, relieving ETS
mediated activation, and making p300/CBP
available for interaction with SMADs to
activate transcription of ECM maintenance
proteins
Invasive breast
carcinoma
(Czuwara-Ladykowska et al., 2002)
Ets-2 MAPK Phopshorylation Increases activation and protein stability Invasive breast cancer,
Leukemia
(Nelson et al., 2010,
Foulds et al., 2004,
Yang et al., 1996)
ELK-1 MAPK Phosphorylation Increased DNA binding affinity and ELK-
1/SRF ternary complex formation, increase
transcriptional activation
Cervical cancer (HeLa) (Lee, 2005,
Latinkic et al., 1996,
Tian and Karin, 1999)
SUMO
conjugating
enzyme UBC9
Sumoylation Recruitment of HDACs, repression of
transcriptional activation
(Yang and Sharrocks, 2004,
Yang et al., 2003)
ELF-1 Agents
unidentified
Phosphorylation Maximal activation of the ELF-1
promoter,converts ELF-1 from 80KDa to
98KDa,dissociates from Rb in cytoplasm
and translocates to nucleus
(Juang et al., 2002)
Glycosylation
Er81 HER2/Neu
signaling; MAPK
Phosphorylation Activates transcription Breast cancer (Bosc et al., 2001,
Janknecht, 2001,
Wang et al., 2011)
MSK1, PKA, Mk2 Suppresses transcriptional activity
p300;P/CAF Acetylation Increases DNA binding affinity and potency
of Er81 TAD; inhibits ubiquitin mediated
degradation.
(Goel and Janknecht, 2003)
SAP-1 MAPK Phosphorylation Increases DNA affinity, promotes ternary
complex, increases transcriptional
activation
(Strahl et al., 1996)
NET Ras-ERK Phosphorylation Converts repressor to activator, stimulates
angiogenesis
(Giovane et al., 1994)
JNK Phosphorylation
SUMO
conjugating
enzyme UBC9
Sumoylation Increases repression (Wasylyk et al., 2005)